Linomide
Linomide is a quinoline derivative immunostimulant which increases NK cell activity and macrophage cytotoxicity. It also inhibits angiogenesis and reduces the secretion of TNF alpha.
Linomide has been investigated as a treatment for some cancers and autoimmune diseases, such as multiple sclerosis and recent-onset Diabetes [mellitus type 1|type I diabetes]. Several trials have been terminated due to serious cardiovascular toxicity.